RxDoctor Payments Data

Matthew Kesler, PA

Physician Assistant · Apple Valley, MNNPI 1831538602

Payments from drug & device makers

$264in general payments, 2019–2025

Across 18 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$83
  • Vanda Pharmaceuticals Inc.$62
  • Neurocrine Biosciences, Inc.$31
  • Almatica Pharma LLC$27
  • Acadia Pharmaceuticals Inc$18
  • Ironshore Pharmaceuticals Inc.$16
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$264100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$264 in reported general payments places this provider in the 80th percentile of 3,121 physician assistant providers in Minnesota.

See all physician assistant providers in Minnesota

Medicare billing

Part B allowed, 2024
$67,357
Medicare patients
215
Services billed
781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate22$191,394
Invega SustennaPaliperidone Palmitate68$161,261
Abilify MaintenaAripiprazole58$158,146
RexultiBrexpiprazole81$118,664
VraylarCariprazine Hcl71$113,630
CaplytaLumateperone Tosylate41$69,002
Risperidone ErRisperidone Microspheres52$55,293
LybalviOlanzapine/Samidorphan Malate16$26,160
TrintellixVortioxetine Hydrobromide45$24,634
Lurasidone Hcl80$19,595
TopamaxTopiramate22$18,747
LatudaLurasidone Hcl13$17,574
Clozapine277$17,171
BelsomraSuvorexant31$13,290
Lisdexamfetamine Dimesylate51$12,069

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$31$191,39422 claims
Almatica Pharma LLCSertraline Hcl$27$4,218318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,121 physician assistant providers in Minnesota.

Other physician assistant in Apple Valley

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →